イリノイ州におけるアルツハイマー病の臨床試験
イリノイ州内の拠点で、アルツハイマー病に関する19件の研究が参加者を募集しています。
イリノイ州内の都市
公式研究テキスト（英語）
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Essential Concepts Research Solutions (ECRS), Palos Hills
被験者募集中第4相
50歳以上 · 全性別 · 2026/09/25更新 · NCT07633470Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- RE:Cognition (Chicago), Chicago
- Great Lakes Clinical Trials Chicago d/b/a Flourish Research Andersonville, Chicago
被験者募集中第3相
50歳〜90歳 · 全性別 · 2026/09/21更新 · NCT07177352A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Great Lakes Clinical Trials - Andersonville, Chicago
- Southern Illinois University School of Medicine, Springfield
被験者募集中第3相
60歳〜85歳 · 全性別 · 2026/09/17更新 · NCT06976203OTC Hearing Aid and MCI
- Northwestern University HA Lab, Evanston
被験者募集中
60歳〜90歳 · 全性別 · 2026/09/04更新 · NCT06112860A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Alexian Brothers Medical Center-Neurosciences ( Site 1017), Elk Grove Village
被験者募集中第2相
50歳〜85歳 · 全性別 · 2026/08/26更新 · NCT07033494A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Re:Cognition Health - Chicago, Chicago
- Ascension Alexian Brothers, Elk Grove Village
被験者募集中第3相
60歳〜85歳 · 全性別 · 2026/08/20更新 · NCT06976216Central Auditory Processing Modulation Underlying Anxiety Reduction Using Clinically Designed Improvisatory Music
- Northwestern University Feinberg School of Medicine, Chicago
被験者募集中
55歳以上 · 全性別 · 2026/08/20更新 · NCT07775625Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- John H. Stroger, Jr. Hospital of Cook County, Chicago
- University of Chicago - Medical Center, Chicago
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/04更新 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Advocate Lutheran General Hospital, Park Ridge
被験者募集中第2/3相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/07/27更新 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Advocate Lutheran General Hospital, Park Ridge
被験者募集中第2/3相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/07/27更新 · NCT05552157Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
- Insigth Hospital and Medical Center Chicago, Chicago
被験者募集中観察研究健康なボランティア歓迎
40歳〜90歳 · 全性別 · 2026/07/14更新 · NCT07701161A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Great Lakes Clinical Trials - Andersonville, Chicago
被験者募集中第3相
55歳以上 · 全性別 · 2026/07/07更新 · NCT07602582Communication Bridge 3 Study
- University of Chicago - American School Building, Chicago
被験者募集中第2相
18歳〜100歳 · 全性別 · 2026/06/01更新 · NCT06191198Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Advocate Medical Group Adult Down Syndrome Center, Park Ridge
被験者募集中観察研究
25歳〜55歳 · 全性別 · 2026/05/18更新 · NCT04165109Late Onset Alzheimer's Disease
- Rush University, Aurora
被験者募集中観察研究健康なボランティア歓迎
55歳以上 · 全性別 · 2026/05/18更新 · NCT05010603Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Flourish Research - Chicago, Chicago
被験者募集中観察研究健康なボランティア歓迎
60歳〜90歳 · 全性別 · 2026/04/15更新 · NCT06584357Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease
- Endeavor Health Systems, Evanston
被験者募集中第3相健康なボランティア歓迎
45歳以上 · 全性別 · 2025/07/30更新 · NCT06254469Feasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related Outcomes
- Advanced Personalized Ideation Center (API) and Gatorade Sports Science Institute (GSSI), PepsiCo Global R&D - Life Sciences, Chicago
被験者募集中観察研究健康なボランティア歓迎
18歳〜65歳 · 全性別 · 2025/06/05更新 · NCT07005895Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)
- Full List of Active Sites, Chicago
被験者募集中観察研究
18歳以上 · 全性別 · 2023/12/14更新 · NCT06170268ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。